Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases

Brain Research Reviews

Volumn 59, Issue 1, 2008, Pages 245-252

  Li, Xiang ^a,b   Li, He ^b   Li, Xiao Jiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Autophagy; Huntingtin; Neurodegeneration; Polyglutamine; Proteasome; Ubiquitin

Indexed keywords

POLYGLUTAMINE; PROTEASOME; UBIQUITIN;

AUTOPHAGY; DEGENERATIVE DISEASE; HUMAN; MISFOLDED PROTEIN; NERVE CELL; NERVE DEGENERATION; NEUROTOXICITY; POLYGLUTAMINE NEURODEGENERATIVE DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; REVIEW;

ANIMALS; AUTOPHAGY; HUMANS; NEURODEGENERATIVE DISEASES; PEPTIDES; PROTEIN FOLDING;

EID: 53749088439     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2008.08.003     Document Type: Review

References (74)

1. Andrew S.E., Goldberg Y.P., Kremer B., Telenius H., Theilmann J., Adam S., Starr E., Squitieri F., Lin B., and Kalchman M.A. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat. Genet. 4 (1993) 398-403
2. Bader N., Jung T., and Grune T. The proteasome and its role in nuclear protein maintenance. Exp. Gerontol. 42 (2007) 864-870
3. Bence N.F., Sampat R.M., and Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 (2001) 1552-1555
4. Bennett E.J., Bence N.F., Jayakumar R., and Kopito R.R. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell 17 (2005) 351-365
5. Bennett E.J., Shaler T.A., Woodman B., Ryu K.Y., Zaitseva T.S., Becker C.H., Bates G.P., Schulman H., and Kopito R.R. Global changes to the ubiquitin system in Huntington's disease. Nature 448 (2007) 704-708
6. Bett J.S., Goellner G.M., Woodman B., Pratt G., Rechsteiner M., and Bates G.P. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target. Hum. Mol. Genet. 15 (2006) 33-44
7. Borrell-Pages M., Zala D., Humbert S., and Saudou F. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol. Life Sci. 63 (2006) 2642-2660
8. Bowman A.B., Yoo S.Y., Dantuma N.P., and Zoghbi H.Y. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum. Mol. Genet. 14 (2005) 679-691
9. Chau V., Tobias J.W., Bachmair A., Marriott D., Ecker D.J., Gonda D.K., and Varshavsky A. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243 (1989) 1576-1583
10. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat. Rev. Mol. Cell Biol. 6 (2005) 79-87
11. Colin E., Zala D., Liot G., Rangone H., Borrell-Pages M., Li X.J., Saudou F., and Humbert S. Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J. 27 (2008) 2124-2134
12. Cornett J., Cao F., Wang C.E., Ross C.A., Bates G.P., Li S.H., and Li X.J. Polyglutamine expansion of huntingtin impairs its nuclear export. Nat. Genet. 37 (2005) 198-204
13. Cummings C.J., Mancini M.A., Antalffy B., DeFranco D.B., Orr H.T., and Zoghbi H.Y. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19 (1998) 148-154
14. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., and Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 (1997) 537-548
15. Deveraux Q., Ustrell V., Pickart C., and Rechsteiner M. A 26 S protease subunit that binds ubiquitin conjugates. J. Biol. Chem. 269 (1994) 7059-7061
16. Diaz-Hernandez M., Hernandez F., Martin-Aparicio E., Gomez-Ramos P., Moran M.A., Castano J.G., Ferrer I., Avila J., and Lucas J.J. Neuronal induction of the immunoproteasome in Huntington's disease. J. Neurosci. 23 (2003) 11653-11661
17. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997) 1990-1993
18. Gusella J.F., MacDonald M.E., Ambrose C.M., and Duyao M.P. Molecular genetics of Huntington's disease. Arch. Neurol. 50 (1993) 1157-1163
19. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., Jones R., Rye D., Ferrante R.J., Hersch S.M., and Li X.J. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19 (1999) 2522-2534
20. Hackam A.S., Singaraja R., Wellington C.L., Metzler M., McCutcheon K., Zhang T., Kalchman M., and Hayden M.R. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141 (1998) 1097-1105
21. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., and Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006) 885-889
22. Hershko A., and Ciechanover A. The ubiquitin system. Annu Rev Biochem. 67 (1998) 425-479
23. Iwata A., Christianson J.C., Bucci M., Ellerby L.M., Nukina N., Forno L.S., and Kopito R.R. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13135-13140
24. Iwata A., Riley B.E., Johnston J.A., and Kopito R.R. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J. Biol. Chem. 280 (2005) 40282-40292
25. Jana N.R., Zemskov E.A., Wang G., and Nukina N. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet. 10 (2001) 1049-1059
26. Jia K., Hart A.C., and Levine B. Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans. Autophagy 3 (2007) 21-25
27. Kang C., You Y.J., and Avery L. Dual roles of autophagy in the survival of Caenorhabditis elegans during starvation. Genes. Dev. 21 (2007) 2161-2171
28. Kawakami T., Suzuki T., Baek S.H., Chung C.H., Kawasaki H., Hirano H., Ichiyama A., Omata M., and Tanaka K. Isolation and characterization of cytosolic and membrane-bound deubiquitinylating enzymes from bovine brain. J. Biochem. 126 (1999) 612-623
29. Kegel K.B., Kim M., Sapp E., McIntyre C., Castano J.G., Aronin N., and DiFiglia M. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J. Neurosci. 20 (2000) 7268-7278
30. King M.A., Hands S., Hafiz F., Mizushima N., Tolkovsky A.M., and Wyttenbach A. Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. Mol. Pharmacol. 73 (2008) 1052-1063
31. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., and Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006) 880-884
32. Komatsu M., Wang Q.J., Holstein G.R., Friedrich Jr. V.L., Iwata J., Kominami E., Chait B.T., Tanaka K., and Yue Z. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14489-14494
33. Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., Ezaki J., Mizushima N., Ohsumi Y., Uchiyama Y., Kominami E., Tanaka K., and Chiba Y. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169 (2005) 425-434
34. Kuma A., Matsui M., and Mizushima N. LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy 3 (2007) 323-328
35. Layfield R., Cavey J.R., and Lowe J. Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders. Ageing Res. Rev. 2 (2003) 343-356
36. Levine B., and Kroemer G. Autophagy in the pathogenesis of disease. Cell 132 (2008) 27-42
37. Li S.H., and Li X.J. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet. 20 (2004) 146-154
38. Li S., and Li X.J. Multiple pathways contribute to the pathogenesis of Huntington disease. Mol. Neurodegener. 1 (2006) 19
39. Li H., Li S.H., Johnston H., Shelbourne P.F., and Li X.J. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat. Genet. 25 (2000) 385-389
40. Lin C.H., Tallaksen-Greene S., Chien W.M., Cearley J.A., Jackson W.S., Crouse A.B., Ren S., Li X.J., Albin R.L., and Detloff P.J. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet. 10 (2001) 137-144
41. Lindsten K., Menendez-Benito V., Masucci M.G., and Dantuma N.P. A transgenic mouse model of the ubiquitin/proteasome system. Nat. Biotechnol. 21 (2003) 897-902
42. Martinez-Vicente M., Sovak G., and Cuervo A.M. Protein degradation and aging. Exp. Gerontol. 40 (2005) 622-633
43. Massey A., Kiffin R., and Cuervo A.M. Pathophysiology of chaperone-mediated autophagy. Int. J. Biochem. Cell Biol. 36 (2004) 2420-2434
44. Mayer A.N., and Wilkinson K.D. Detection, resolution, and nomenclature of multiple ubiquitin carboxyl-terminal esterases from bovine calf thymus. Biochemistry 28 (1989) 166-172
45. Miasari M., Puthalakath H., and Silke J. Ubiquitylation and cancer development. Curr. Cancer Drug Targets 8 (2008) 118-123
46. Michalik A., and Van Broeckhoven C. Proteasome degrades soluble expanded polyglutamine completely and efficiently. Neurobiol. Dis. 16 (2004) 202-211
47. Mizushima N., Levine B., Cuervo A.M., and Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 451 (2008) 1069-1075
48. Orr H.T., and Zoghbi H.Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30 (2007) 575-621
49. Orr A.L., Li S., Wang C.E., Li H., Wang J., Rong J., Xu X., Mastroberardino P.G., Greenamyre J.T., and Li X.J. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J. Neurosci. 28 (2008) 2783-2792
50. Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., Schwartz S.L., DiProspero N.A., Knight M.A., Schuldiner O., Padmanabhan R., Hild M., Berry D.L., Garza D., Hubbert C.C., Yao T.P., Baehrecke E.H., and Taylor J.P. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447 (2007) 859-863
51. Perutz M.F., Johnson T., Suzuki M., and Finch J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 5355-5358
52. Petersen A., Larsen K.E., Behr G.G., Romero N., Przedborski S., Brundin P., and Sulzer D. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum. Mol. Genet. 10 (2001) 1243-1254
53. Pratt G., and Rechsteiner M. Proteasomes cleave at multiple sites within polyglutamine tracts: activation by PA28gamma(K188E). J. Biol. Chem. 283 (2008) 12919-12925
54. Qin Z.H., Wang Y., Kegel K.B., Kazantsev A., Apostol B.L., Thompson L.M., Yoder J., Aronin N., and DiFiglia M. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum. Mol. Genet. 12 (2003) 3231-3244
55. Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G., Scaravilli F., Easton D.F., Duden R., O'Kane C.J., and Rubinsztein D.C. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36 (2004) 585-595
56. Ravikumar B., Berger Z., Vacher C., O'Kane C.J., and Rubinsztein D.C. Rapamycin pre-treatment protects against apoptosis. Hum. Mol. Genet. 15 (2006) 1209-1216
57. Rubinsztein D.C., Gestwicki J.E., Murphy L.O., and Klionsky D.J. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 6 (2007) 304-312
58. Sapp E., Schwarz C., Chase K., Bhide P.G., Young A.B., Penney J., Vonsattel J.P., Aronin N., and DiFiglia M. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 42 (1997) 604-612
59. Shibata M., Lu T., Furuya T., Degterev A., Mizushima N., Yoshimori T., MacDonald M., Yankner B., and Yuan J. Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J. Biol. Chem. 281 (2006) 14474-14485
60. Skinner P.J., Vierra-Green C.A., Clark H.B., Zoghbi H.Y., and Orr H.T. Altered trafficking of membrane proteins in Purkinje cells of SCA1 transgenic mice. Am. J. Pathol. 159 (2001) 905-913
61. Snell R.G., MacMillan J.C., Cheadle J.P., Fenton I., Lazarou L.P., Davies P., MacDonald M.E., Gusella J.F., Harper P.S., and Shaw D.J. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat. Genet. 4 (1993) 393-397
62. Seo H., Sonntag K.C., and Isacson O. Generalized brain and skin proteasome inhibition in Huntington's disease. Ann. Neurol. 56 (2004) 319-328
63. Taylor J.P., Tanaka F., Robitschek J., Sandoval C.M., Taye A., Markovic-Plese S., and Fischbeck K.H. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12 (2003) 749-757
64. Venkatraman P., Wetzel R., Tanaka M., Nukina N., and Goldberg A.L. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol. Cell 14 (2004) 95-104
65. Vernace V.A., Schmidt-Glenewinkel T., and Figueiredo-Pereira M.E. Aging and regulated protein degradation: who has the UPPer hand?. Aging Cell 6 (2007) 599-606
66. Vonsattel J.P., and DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57 (1998) 369-384
67. Waelter S., Boeddrich A., Lurz R., Scherzinger E., Lueder G., Lehrach H., and Wanker E.E. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol. Biol. Cell 12 (2001) 1393-1407
68. Wang C.E., Tydlacka S., Orr A.L., Yang S.H., Graham R.K., Hayden M.R., Li S., Chan A.W., and Li X.J. Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease. Hum. Mol. Genet. 17 (2008) 2738-2751
69. Wang J., Wang C.E., Orr A., Tydlacka S., Li S.H., and Li X.J. Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J. Cell Biol. 180 (2008) 1177-1189
70. Wheeler V.C., White J.K., Gutekunst C.A., Vrbanac V., Weaver M., Li X.J., Li S.H., Yi H., Vonsattel J.P., Gusella J.F., Hersch S., Auerbach W., Joyner A.L., and MacDonald M.E. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum. Mol. Genet. 9 (2000) 503-513
71. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell. 124 (2006) 471-484
72. Yamamoto A., Cremona M.L., and Rothman J.E. Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J. Cell Biol. 172 (2006) 719-731
73. Zhang L., Yu J., Pan H., Hu P., Hao Y., Cai W., Zhu H., Yu A.D., Xie X., Ma D., and Yuan J. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 19023-19028
74. Zhou H., Cao F., Wang Z., Yu Z.X., Nguyen H.P., Evans J., Li S.H., and Li X.J. Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity. J. Cell Biol. 163 (2003) 109-118